KRRO/ 11/13/2025 · 6:58 AM Korro Bio Announces Major Restructuring and Program Shifts Korro Bio is focusing on new genetic medicines (GalNAc programs) after poor trial results for KRRO-110, pausing its Novo Nordisk partnership, and reducing its staff by 34%.